New online! Chiral phosphorus by catalyst design: Nature Catalysis, Published online: 05 August 2026; doi:10.1038/s41929-026-01594-9Phosphorothioate modifications are central to oligonucleotide medicines, but their stereocontrolled syntheses has proven challenging. A catalyst-controlled loading…
Chiral phosphorus by catalyst design
Nature Catalysis, Published online: 05 August 2026; doi:10.1038/s41929-026-01594-9Phosphorothioate modifications are central to oligonucleotide medicines, but their stereocontrolled syntheses has proven challenging. A catalyst-controlled loading strategy now delivers stereodefined building blocks for oligonucleotides and cyclic dinucleotides.
go.nature.com